PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+3.01%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$303M
AUM Growth
–
Cap. Flow
+$303M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$110M |
| 2 |
Vaxcyte
PCVX
|
$59.1M |
| 3 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$35.6M |
| 4 |
INZY
Inozyme Pharma
INZY
|
$32.8M |
| 5 |
Aligos Therapeutics
ALGS
|
$24.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $110M | 36.29% | +1,083,344 | New | +$110M |
|
|
2
Vaxcyte
PCVX
$4B
| $59.1M | 19.47% | +2,222,970 | New | +$59.1M |
|
|
AKUS
3
DELISTED
Akouos, Inc. Common Stock
AKUS
| $35.6M | 11.73% | +1,794,088 | New | +$35.6M |
|
|
INZY
4
DELISTED
Inozyme Pharma
INZY
| $32.8M | 10.83% | +1,591,154 | New | +$32.8M |
|
|
5
Aligos Therapeutics
ALGS
$73.3M
| $24.2M | 7.99% | +876,548 | New | +$24.2M |
|
6
Arcutis Biotherapeutics
ARQT
$1.86B
| $18.9M | 6.23% | +671,716 | New | +$18.9M |
|
|
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $18.8M | 6.19% | +1,598,379 | New | +$18.8M |
|
|
ETTX
8
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $2.92M | 0.96% | +1,180,178 | New | +$2.92M |
|
9
Iterum Therapeutics
ITRM
$30.2M
| $935K | 0.31% | +945,085 | New | +$935K |
|